Lixiao Xing

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

Zezhong Liu, Jie Zhou, Wei Xu et al. · Cell Research · 2022 · 99 citations · Full text

A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern

Lixiao Xing, Xinfeng Xu, Wei Xu et al. · Viruses · 2022 · 40 citations · Full text

Viral Replication, Synthetic Virology, Prolonged Duration +14

A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases

Jie Zhou, Wei Xu, Zezhong Liu et al. · Acta Pharmaceutica Sinica B · 2021 · 35 citations · Full text

STING agonist-based ER-targeting molecules boost antigen cross-presentation

Xiafeng Wang, Zhangping Huang, Lixiao Xing et al. · Nature · 2025 · 28 citations · Full text

Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target

Lixiao Xing, Zhimin Liu, Xinling Wang et al. · Cell · 2025 · 27 citations

Virus Structure, Molecular Virology, Early Fusion Intermediate +8